Robert Mróz

5.0k total citations
79 papers, 795 citations indexed

About

Robert Mróz is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Molecular Biology. According to data from OpenAlex, Robert Mróz has authored 79 papers receiving a total of 795 indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Pulmonary and Respiratory Medicine, 23 papers in Physiology and 17 papers in Molecular Biology. Recurrent topics in Robert Mróz's work include Chronic Obstructive Pulmonary Disease (COPD) Research (26 papers), Asthma and respiratory diseases (13 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (10 papers). Robert Mróz is often cited by papers focused on Chronic Obstructive Pulmonary Disease (COPD) Research (26 papers), Asthma and respiratory diseases (13 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (10 papers). Robert Mróz collaborates with scholars based in Poland, United States and Germany. Robert Mróz's co-authors include E Chyczewska, Adam Hołownia, William MacNee, Jan J. Braszko, Ellen Drost, Roel P. F. Schins, Anna Stasiak‐Barmuta, Esther García Gil, Kenneth Donaldson and Rosa Segarra and has published in prestigious journals such as Annals of Oncology, European Respiratory Journal and Frontiers in Microbiology.

In The Last Decade

Robert Mróz

72 papers receiving 772 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert Mróz Poland 15 392 256 161 102 98 79 795
Martina Dörger Germany 17 274 0.7× 122 0.5× 145 0.9× 67 0.7× 54 0.6× 25 843
Jinming Gao China 17 366 0.9× 330 1.3× 184 1.1× 17 0.2× 55 0.6× 65 869
Matthew J. Justice United States 18 334 0.9× 258 1.0× 493 3.1× 22 0.2× 130 1.3× 29 1.1k
Francine Uwambayinema Belgium 15 392 1.0× 56 0.2× 187 1.2× 132 1.3× 25 0.3× 23 889
Dunqiang Ren China 16 217 0.6× 194 0.8× 155 1.0× 10 0.1× 80 0.8× 40 712
Panagiotis Vasileiou Greece 15 60 0.2× 213 0.8× 265 1.6× 48 0.5× 44 0.4× 31 902
Diane Allen‐Gipson United States 17 226 0.6× 119 0.5× 264 1.6× 10 0.1× 56 0.6× 36 751
Rachel A. Collins Australia 13 266 0.7× 183 0.7× 162 1.0× 12 0.1× 23 0.2× 17 746
Cecilia Carubbi Italy 18 67 0.2× 86 0.3× 295 1.8× 53 0.5× 48 0.5× 53 1.0k

Countries citing papers authored by Robert Mróz

Since Specialization
Citations

This map shows the geographic impact of Robert Mróz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Mróz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Mróz more than expected).

Fields of papers citing papers by Robert Mróz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert Mróz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Mróz. The network helps show where Robert Mróz may publish in the future.

Co-authorship network of co-authors of Robert Mróz

This figure shows the co-authorship network connecting the top 25 collaborators of Robert Mróz. A scholar is included among the top collaborators of Robert Mróz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert Mróz. Robert Mróz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wojnar, Marcin, Jerzy Samochowiec, Joanna Rymaszewska, et al.. (2023). Management of nicotine dependence in patients with psychiatric disorders – recommendations of the Polish Psychiatric Association – part II. Psychiatria Polska. 58(3). 419–431. 1 indexed citations
2.
Minarowski, Łukasz, et al.. (2023). Non-Invasive Cardiac Output Measurement Using Inert Gas Rebreathing Method during Cardiopulmonary Exercise Testing—A Systematic Review. Journal of Clinical Medicine. 12(22). 7154–7154. 2 indexed citations
3.
Minarowski, Łukasz, et al.. (2023). Impact of COVID-19 in Patients with Lung Cancer: A Descriptive Analysis. International Journal of Environmental Research and Public Health. 20(2). 1583–1583. 4 indexed citations
4.
Crapo, James D., Abhya Gupta, David A. Lynch, et al.. (2023). Baseline characteristics from a 3-year longitudinal study to phenotype subjects with COPD: the FOOTPRINTS study. Respiratory Research. 24(1). 290–290. 2 indexed citations
5.
Charkiewicz, Radosław, Anetta Sulewska, Robert Mróz, et al.. (2023). Serum Insights: Leveraging the Power of miRNA Profiling as an Early Diagnostic Tool for Non-Small Cell Lung Cancer. Cancers. 15(20). 4910–4910. 6 indexed citations
6.
Skłodowski, Karol, Łukasz Suprewicz, Magdalena Zakrzewska, et al.. (2023). Ceragenins exhibit bactericidal properties that are independent of the ionic strength in the environment mimicking cystic fibrosis sputum. Frontiers in Microbiology. 14. 1290952–1290952. 3 indexed citations
7.
Minarowski, Łukasz, et al.. (2022). Multiorgan sarcoidosis as a diabetes insipidus mask. Endocrinology Diabetes and Metabolism Case Reports. 2022. 1 indexed citations
8.
Crapo, James D., Abhya Gupta, David A. Lynch, et al.. (2021). FOOTPRINTS study protocol: rationale and methodology of a 3-year longitudinal observational study to phenotype patients with COPD. BMJ Open. 11(3). e042526–e042526. 2 indexed citations
9.
Skoczyński, Szymon, et al.. (2019). Is It Possible to Predict Whether BAL Salvage Is Going to Be Diagnostic?. Advances in respiratory medicine. 87(1). 20–25. 3 indexed citations
10.
Mróz, Robert, Paweł Lisowski, Agnieszka Tycińska, et al.. (2015). Anti-inflammatory effects of atorvastatin treatment in chronic obstructive pulmonary disease. A controlled pilot study.. PubMed. 66(1). 111–28. 45 indexed citations
11.
Wielgat, Przemysław, Robert Mróz, Anna Stasiak‐Barmuta, et al.. (2014). Inhaled Corticosteroids Increase Siglec-5/14 Expression in Sputum Cells of COPD Patients. Advances in experimental medicine and biology. 839. 1–5. 17 indexed citations
12.
Hołownia, Adam, Przemysław Wielgat, Anna Stasiak‐Barmuta, et al.. (2014). Tregs and HLA-DR Expression in Sputum Cells of COPD Patients Treated with Tiotropium and Formoterol. Advances in experimental medicine and biology. 839. 7–12. 4 indexed citations
13.
Beier, Jutta, Anne‐Marie Kirsten, Robert Mróz, et al.. (2013). Improvement in COPD symptoms with aclidinium bromide vs placebo and tiotropium: A phase IIIb study. European Respiratory Journal. 42(Suppl 57). 184–184. 2 indexed citations
14.
Beier, Jutta, Anne‐Marie Kirsten, Robert Mróz, et al.. (2013). Efficacy and safety of aclidinium bromide vs placebo and tiotropium in COPD: A phase IIIb study. European Respiratory Journal. 42(Suppl 57). 185–185. 1 indexed citations
15.
Mróz, Robert, et al.. (2012). sVEGF R1 and Tie-2 Levels During Chemotherapy of Lung Cancer Patients. Advances in experimental medicine and biology. 756. 313–319. 4 indexed citations
16.
Hołownia, Adam, et al.. (2010). Ttiotropium increases cytosolic muscarinic M3 receptors and acetylated H3 histone proteins in induced sputum cells of COPD patients. European journal of medical research. 15(S2). 64–7. 8 indexed citations
17.
Mróz, Robert, Adam Hołownia, E Chyczewska, & Jan J. Braszko. (2008). Chronic obstructive pulmonary disease: an update on nuclear signaling related to inflammation and anti-inflammatory treatment.. PubMed. 59 Suppl 6. 35–42. 11 indexed citations
18.
Mróz, Robert, Mirosław Kozłowski, Andrzej Baniukiewicz, et al.. (2008). Severe respiratory distress caused by central airway obstruction treated with self-expandable metallic stents.. PubMed. 59 Suppl 6. 491–7. 29 indexed citations
19.
Hołownia, Adam, et al.. (2008). Ruthenium red protects HepG2 cells overexpressing CYP2E1 against acetaminophen cytotoxicity. Naunyn-Schmiedeberg s Archives of Pharmacology. 379(1). 27–35. 2 indexed citations
20.
Chyczewska, E, et al.. (1997). IL-2 concentration in bronchoalveolar lavage fluid (BALF) of non-small cell lung cancer (NSCLC) patients.. PubMed. 42 Suppl 1. 136–45. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Martina Dörger Breakdown of academic impact, for papers by Jinming Gao Breakdown of academic impact, for papers by Matthew J. Justice Breakdown of academic impact, for papers by Francine Uwambayinema Breakdown of academic impact, for papers by Dunqiang Ren Breakdown of academic impact, for papers by Panagiotis Vasileiou Breakdown of academic impact, for papers by Diane Allen‐Gipson Breakdown of academic impact, for papers by Rachel A. Collins Breakdown of academic impact, for papers by Cecilia Carubbi
Rankless by CCL
2026